Main menu

Precision genomics for hereditary cancer with adaptive sampling

The Oxford Nanopore Hereditary Cancer Panel offers comprehensive germline variant analysis across 258 cancer predisposition genes. The panel uses adaptive sampling: a fast and flexible on-sequencer target enrichment methodology. No lengthy library preparation, baits, or primers required.

Why choose the Oxford Nanopore Hereditary Cancer Panel?

One consolidated assay for deeper genomic and epigenomic insight
Rapid, streamlined sequencing — no batching required
Flexible enrichment. Scalable sequencing. Built for every lab.
hereditary cancer panel coverage depth
Recommended device for the Hereditary Cancer Panel

PromethION 24

The PromethION 24 (P24) is a high-throughput sequencing device featuring 24 independent flow cells positions, allowing users to sequence multiple samples simultaneously or flexibly scale their experiments.

PromethION 24 Sequencing device

Flyer: Hereditary Cancer Panel — 2 pages

Hereditary Cancer Panel flyer: targeted sequencing via adaptive sampling

Accurately resolve complex structural variants (SVs), single nucleotide variants (SNVs), and insertions/deletions (indels) with the Oxford Nanopore Hereditary Cancer Panel — a comprehensive sequencing assay.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag